NOV
60
2
CAG
34
-3
FLS
57
2
NSC
48
3
APH
65
-2
BXP
54
10
KO
57
-2
PNR
56
2
VMC
60
3
AME
48
-12
LEN
50
2
PH
66
3
OI
37
4
RHI
40
2
KMB
39
-3
AN
47
3
CL
70
-4
CAT
66
2
TGNA
64
2
CME
37
3
NOV
60
2
CAG
34
-3
FLS
57
2
NSC
48
3
APH
65
-2
BXP
54
10
KO
57
-2
PNR
56
2
VMC
60
3
AME
48
-12
LEN
50
2
PH
66
3
OI
37
4
RHI
40
2
KMB
39
-3
AN
47
3
CL
70
-4
CAT
66
2
TGNA
64
2
CME
37
3
Financhill
Back

Annaly Capital Management Vs. Keros Therapeutics Industry Stock Comparison

Sell
19

NLY
Annaly Capital Management

Last Price:
19.05
Seasonality Move:
-2.01%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
19
Annaly Capital Management (NLY) is a Sell

Is Annaly Capital Management a Buy, Sell or Hold?

  • The current Annaly Capital Management [NLY] share price is $19.06. The Score for NLY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NLY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLY Stock Price Chart

What is Annaly Capital Management's stock price today?

  • The Annaly Capital Management share price today is $19.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLY is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

NLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 36.18 Sell
Chaikin Money Flow: -979818 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.45 - 20.07) Sell
Bollinger Bands (100): (18.74 - 19.96) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

NLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.84 Sell
20-day SMA: 19.86 Sell
50-day SMA: 19.57 Sell
200-day SMA: 18.91 Buy
8-day EMA: 19.73 Sell
20-day EMA: 19.8 Sell
50-day EMA: 19.65 Sell
200-day EMA: 19.4 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

Annaly Capital Management Earnings Growth & NLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Annaly Capital Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):